, 1991) and activation of cAMP–response element-binding protein (CREB) take place in the mesolimbic system after exposure to diverse drugs of abuse such as ethanol, opiates, cocaine, and amphetamine (Asher et al., 2002; Carlezon et al., 1998; Lu et al., 2003; McClung and Nestler, 2003; Shaw-Lutchman et al., 2002, 2003).
Sample text:```The ¬¨¬µ-opioid receptor agonist morphine also induced inhibitory effects in both assays, in accordance with previous reports describing the opiate-mediated inhibition of the BSL evoked in mice by excitatory amino acids and neurokinins (Aanonsen et al. 1987; Takahasi et al. 1987; Wilcox 1988).```
Sample intent: result
Sample text:```Previous studies revealed that acylcarnitines were elevated early after APAP treatment and that their elevation was indicative of mitochondrial damage and dysfunction.(15,19) In the present study these observations were confirmed, as palmitoylcarnitine was elevated by toxic doses of APAP and maintained at normal levels (compared with untreated controls) by Wy-14,643 pretreatment.```
Sample intent: result



Sample text:```Although the time-constants of the learning window used in this study were much shorter than those reported for hippocampal neurons by Bi and Poo [27] (viz.```
Sample intent: background



Sample text:```1996) and then to the effector enzyme, namely phospholipase C-b 2 (PLC-b 2) (Adler et al. 2000).```
Sample intent: method



Sample text:```Secondly, this effect was shown to be selectively due to CCK2 activation (Ladurelle et al. 1997) through mechanisms involving δ-opioid (Daugé et al. 1999) and D1-dopamine receptors (Ladurelle et al. 1993) that could be blocked by the selective antagonists naltrindole (a δ antagonist), and SCH23,390.```
Sample intent: method



Sample text:```We have performed studies regarding lip hypoesthesia after SSRO using TSEP for long time (Nakagawa et al., 1997, 2001, 2003; Hashiba et al., 2007; Takazakura et al., 2007; Hashiba et al., 2008; Ueki et al., 2012, 2013a, 2013b).```
Sample intent: background
Sample text:```In the last 5 years, it has been published as the most comprehensive study on the distribution of PLCb1 in the mouse brain, showing that it is highly expressed in the somatodendritic compartment of principal neurons of the telencephalon (Fukaya et al., 2008).```
Sample intent: method



Sample text:```These results corroborate studies that have demonstrated an enhancement of other types of reward with Dz-specific agonists [6,17,21,52].```
Sample intent: result



Sample text:```For experiments measuring the effect of Sch-28080 and ouabain on pHi recovery in ICs, only basolateral Cl removal was used to differentiate IC types (15, 17).```
Sample intent: background



Sample text:```Catecholamines, and particularly DA, are believed to increase the efficiency of cortical processing by augmenting the signal-tonoise ratio or gain within cortical networks [4,37–39].```
Sample intent: method



Sample text:```Previous studies revealed that acylcarnitines were elevated early after APAP treatment and that their elevation was indicative of mitochondrial damage and dysfunction.(15,19) In the present study these observations were confirmed, as palmitoylcarnitine was elevated by toxic doses of APAP and maintained at normal levels (compared with untreated controls) by Wy-14,643 pretreatment.```
Sample intent: result



Sample text:```…(LING)] thalamus (THA), as well as limbic/paralimbic regions [e.g. insula, superior temporal pole and inferior orbitofrontal cortex] (Table 2), which is in accordance with previous findings on functional brain networks constructed using resting-state fMRI (Achard et al., 2006; He et al., 2009b).```
Sample intent: result



Sample text:```Secondly, this effect was shown to be selectively due to CCK2 activation (Ladurelle et al. 1997) through mechanisms involving δ-opioid (Daugé et al. 1999) and D1-dopamine receptors (Ladurelle et al. 1993) that could be blocked by the selective antagonists naltrindole (a δ antagonist), and SCH23,390.```
Sample intent: method



Sample text:```Intriguingly, using MPRs-deficient MEF cells, mouse and human CLN5 have been shown to reach lysosomes in an MPRindependent manner [12].```
Sample intent: background



Sample text:```In line with our results, several previous studies demonstrated the anti-proliferative effect of PPARs agonists in several cell types [11-15].```
Sample intent: result



Sample text:```1996) and then to the effector enzyme, namely phospholipase C-b 2 (PLC-b 2) (Adler et al. 2000).```
Sample intent: method